⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29246278 | 0.89 | — | — | |
| SCHEMBL8880037 | 0.85 | — | — | |
| Benzothiophene SCHEMBL28770302 | 0.84 | — | — | |
| SCHEMBL191345 | 0.76 | ALDH1A1 (0.30) | — | |
| SCHEMBL4515091 | 0.71 | — | — | |
| SCHEMBL2047647 | 0.69 | — | — | |
| SCHEMBL9044942 | 0.68 | NPSR1 (0.31) | — | |
| SCHEMBL29263176 | 0.68 | — | — | |
| SCHEMBL4488759 | 0.67 | — | — | |
| SCHEMBL29229513 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 760 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118047753-A | Pyrrolecarboxyl carbazole derivatives and their use in phosphorescent materials | 三峡大学 | 2024-05-17 | — | — | CN | claimed |
| US-20230416782-A1 | ENHANCED NANOPARTICLE DELIVERY SYSTEMS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-12-28 | — | — | US | claimed |
| EP-4259207-A1 | ENHANCED NANOPARTICLE DELIVERY SYSTEMS | Children's Hospital Medical Center (US) | 2023-10-18 | — | — | EP | claimed |
| US-20220202950-A1 | COMPOSITIONS COMPRISING BACTERIALLY DERIVED INTACT MINICELLS FOR THERANOSTIC APPLICATIONS | ENGENEIC MOLECULAR DELIVERY PTY LTD (AU) | 2022-06-30 | — | — | US | claimed |
| WO-2022125784-A1 | ENHANCED NANOPARTICLE DELIVERY SYSTEMS | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2022-06-16 | — | — | WO | claimed |
| CN-113912621-A | Containing SO2Spiro pyrrolocarbazoles and application thereof | 北京云基科技有限公司 | 2022-01-11 | — | — | CN | claimed |
| CN-113880861-A | Containing SO2Spiro pyrrolocarbazoles compounds and application thereof | 北京云基科技有限公司 | 2022-01-04 | — | — | CN | claimed |
| WO-2020222161-A1 | COMPOSITIONS COMPRISING BACTERIALLY DERIVED INTACT MINICELLS FOR THERANOSTIC APPLICATIONS | ENGENEIC MOLECULAR DELIVERY PTY LTD (AU) | 2020-11-05 | — | — | WO | claimed |
| EP-2336315-B1 | Enzymatic encoding methods for efficient synthesis of large libraries | NUEVOLUTION AS (DK) | 2017-07-19 | — | — | EP | claimed |
| US-9650614-B2 | Anaplastic lymphoma kinase (ALK) as oncoantigen for lymphoma vaccination | CHIARLE, Roberto (IT) | 2017-05-16 | — | — | US | claimed |
| US-5705511-A | ENZYME INHIBITORS, ANTIINFLAMMATORY, TROPHIC FACTOR, ANTICANCER CELL GROWTH | CEPHALON, INC. (US) | 1998-01-06 | — | — | US | claimed |
| CN-1035878-C | Indolopyrrolocarbazole derivatives | BANYU PHARMA CO LTD (JP) | 1997-09-17 | — | — | CN | claimed |
| EP-0785938-A1 | FUSED PYRROLOCARBAZOLES | CEPHALON, INC. (US) | 1997-07-30 | — | — | EP | claimed |
| EP-0768311-A1 | PYRROLOCARBAZOLE DERIVATIVES | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1997-04-16 | — | — | EP | claimed |
| US-5594009-A | KINASE INHIBITORS, TROPHIC FACTOR-INDUCED ACTIVITY ENHANCEMENT, CELL SURVIVAL | CEPHALON, INC. (US) | 1997-01-14 | — | — | US | claimed |
| US-5591855-A | KINASE INHIBITORS, TROPHIC FACTOR-INDUCED ACTIVITY ENHANCEMENT, CELL SURVIVAL | CEPHALON, INC. (US) | 1997-01-07 | — | — | US | claimed |
| WO-1996011933-A1 | FUSED PYRROLOCARBAZOLES | CEPHALON, INC. (US) | 1996-04-25 | — | — | WO | claimed |
| US-5475110-A | Treating nervous system disorders and inflammation, inhibiting protein and tyrosine kinases, inhibiting cell growth | CEPHALON, INC. (US) | 1995-12-12 | — | — | US | claimed |
| CN-1075482-A | Indoles and pyrrolo carbazole derivatives | BANYU PHARMA CO LTD (JP) | 1993-08-25 | — | — | CN | claimed |
| EP-0362695-B1 | PYRROLOCARBAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1991-04-03 | — | — | EP | claimed |